Apellis Pharmaceuticals, Inc. (APLS): 4 filed May 14, 2026

Form type

4

Filing date

May 14, 2026

Accession number

0001193125-26-224585

Filer

Apellis Pharmaceuticals, Inc. (CIK 1492422)